It is a great honor and privilege to be announced as the new Editor-in-Chief of The International Journal of Cardiovascular Imaging. Cardiovascular imaging is an interdisciplinary, cross-sectional field and encompasses a wide range of techniques, including echocardiography, cardiovascular computed tomography, cardiovascular magnetic resonance, nuclear cardiology, X-ray angiography, and intravascular imaging. In the past, when mono-modality approaches led to competition among techniques and departments, today, we are aiming for a “patient-centered” multimodality imaging approach that guides the selection of either a single or a combination of different cardiovascular imaging modalities based on the specific clinical question to address it (Fig. 1). Cardiovascular imaging has evolved beyond being merely a diagnostic tool; it now stands as a fundamental element in different aspects of the care of all cardiovascular patients. This includes, but is not limited to, areas such as coronary artery disease, preventive cardiology, heart failure, congenital heart disease, structural heart disease, valvular heart disease, patients with rhythm disorders, cardiomyopathies and vascular disease. Its pivotal role encompasses risk assessment, treatment planning, guiding during interventions, and monitoring of treatment success (Fig. 2). With my experience as a cardiologist and the director of multimodality cardiac imaging at the University Hospital Bern in Switzerland, where I am responsible for echocardiography, cardiac computed tomography, cardiac magnetic resonance, and nuclear cardiology, working closely with the departments of radiology and nuclear medicine, I am committed to continuing my mission of enhancing the accessibility of cardiovascular imaging for all cardiovascular caregivers and furthering its integration into clinical practice. Therefore, the target audience of the journal extends beyond cardiovascular imagers in cardiology, radiology, and nuclear medicine and includes professionals from all allied disciplines that utilize imaging, such as general cardiologists, interventional cardiologists, heart failure specialists, electrophysiologists, preventive cardiologists, and cardiovascular surgeons.
Fig. 1
Choosing the right imaging modality. This figure depicts how a multimodal, patient-centered approach involves choosing the appropriate cardiovascular imaging modality, or a combination thereof, based on the clinical question
Fig. 2
Areas of Multimodality Cardiovascular Imaging. This figure illustrates how cardiovascular imaging plays a crucial role not only in diagnostics but also in planning therapy, simulation, guiding therapy during interventions, and monitoring therapy
×
×
×
…
Anzeige
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.
Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.
Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.
Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.
Update Kardiologie
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.
